AIP insider files Form 144 for 10,000-share sale; recent 9,448 shares sold

Rhea-AI Filing Summary

Form 144 notice for Arteris, Inc. (AIP) reports a proposed sale of 10,000 common shares to be executed through Morgan Stanley Smith Barney on 09/15/2025 with an aggregate market value of $87,500. The filer acquired these shares the same day by exercise of stock options and paid in cash. The filing also discloses insider sales over the prior three months totaling 9,448 shares for aggregate gross proceeds of $85,168.03, executed under both regular and Rule 10b5-1 plans. The notice includes the filer’s representation that no undisclosed material adverse information is known.

Positive

• Full disclosure of proposed sale details including broker, share count, market value, and acquisition method
• Previous 10b5-1 plan sales are identified, indicating trades may be preplanned and compliant
• Insider representation that no undisclosed material adverse information is known

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider planning to sell newly exercised shares; recent systematic sales totaled 9,448 shares for $85k.

The filing shows an insider will sell 10,000 shares acquired by option exercise and paid in cash, using Morgan Stanley Smith Barney as broker. Recent transactions include multiple 10b5-1 plan sales, indicating preplanned disposals rather than ad hoc liquidity sales. The disclosed market values are modest relative to typical public-company market caps; this appears routine rather than a materially disruptive event for investors.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 requirements; includes Rule 10b5-1 sales and the required insider certifications.

The notice provides the required representations about lack of undisclosed material information and notes a trading plan for some sales. Including date of acquisition (option exercise) and matching sale date for the proposed block is appropriate. From a governance perspective, documentation of 10b5-1 activity and the filing’s completeness reduce regulatory risk, and the transactions appear administratively routine.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	87500.00	42649917	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Exercise of Stock Options	Issuer			10000	09/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/09/2025	2278	19793.66
10b5-1 Sales for PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/08/2025	424	3807.52
PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	258	2306.96
10b5-1 Sales for PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/03/2025	3609	33370.77
PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/02/2025	2879	25889.12

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Arteris, Inc. (AIP) disclose?

It discloses a proposed sale of 10,000 common shares via Morgan Stanley Smith Barney valued at $87,500, acquired by option exercise and paid in cash.

When were the shares to be sold acquired?

The 10,000 shares were reported as acquired on 09/15/2025 through the exercise of stock options.

Has the filer sold shares recently?

Yes; the filing lists 9,448 shares sold in the past three months for aggregate gross proceeds of $85,168.03 under both 10b5-1 plans and direct sales.

Through which broker will the proposed sale be executed?

The filing names Morgan Stanley Smith Barney LLC as the broker for the proposed 10,000-share sale.

Does the filing state whether the filer knows of undisclosed material information?

Yes; by signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.